Jeffrey Zekaukas
Stock Analyst at JP Morgan
(1.59)
# 3,130
Out of 4,784 analysts
19
Total ratings
33.33%
Success rate
1.52%
Average return
Main Sectors:
Stocks Rated by Jeffrey Zekaukas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOS The Mosaic Company | Upgrades: Overweight | $26 → $29 | $27.25 | +6.42% | 4 | Mar 3, 2025 | |
| EMN Eastman Chemical Company | Maintains: Overweight | $110 → $112 | $87.05 | +28.66% | 3 | Feb 3, 2025 | |
| ECL Ecolab | Downgrades: Neutral | $200 → $220 | $249.51 | -11.83% | 5 | Feb 14, 2024 | |
| LYB LyondellBasell Industries | Upgrades: Overweight | $95 → $100 | $69.82 | +43.23% | 3 | Feb 5, 2024 | |
| AVY Avery Dennison | Maintains: Overweight | $185 → $218 | $175.77 | +24.03% | 2 | Feb 1, 2024 | |
| LLY Eli Lilly and Company | Maintains: Equal-Weight | $148 → $157 | $822.51 | -80.91% | 2 | Aug 14, 2020 |
The Mosaic Company
Mar 3, 2025
Upgrades: Overweight
Price Target: $26 → $29
Current: $27.25
Upside: +6.42%
Eastman Chemical Company
Feb 3, 2025
Maintains: Overweight
Price Target: $110 → $112
Current: $87.05
Upside: +28.66%
Ecolab
Feb 14, 2024
Downgrades: Neutral
Price Target: $200 → $220
Current: $249.51
Upside: -11.83%
LyondellBasell Industries
Feb 5, 2024
Upgrades: Overweight
Price Target: $95 → $100
Current: $69.82
Upside: +43.23%
Avery Dennison
Feb 1, 2024
Maintains: Overweight
Price Target: $185 → $218
Current: $175.77
Upside: +24.03%
Eli Lilly and Company
Aug 14, 2020
Maintains: Equal-Weight
Price Target: $148 → $157
Current: $822.51
Upside: -80.91%